This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians

This study has been completed.
Foundation for Informed Medical Decision Making
Olmsted Medical Center
Information provided by (Responsible Party):
Victor Montori, Mayo Clinic Identifier:
First received: July 28, 2009
Last updated: February 1, 2016
Last verified: February 2016

Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making approach with patients, allowing the clinician and patient to weigh potential fracture risk (without treatment), versus risk reduction with medication (including side effects and costs). OSTEOPOROSIS CHOICE II will test the effectiveness of:

  • FRAX
  • FRAX + decision aid
  • Usual care (no decision aid and no FRAX given to clinician)

Condition Intervention
Osteoporosis Osteopenia Fragility Fractures Behavioral: FRAX + Decision Aid Behavioral: FRAX estimated fracture risk

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Supportive Care
Official Title: Wiser Choices In Osteoporosis Choice II

Resource links provided by NLM:

Further study details as provided by Victor Montori, Mayo Clinic:

Primary Outcome Measures:
  • Medication start/stop, knowledge, and patient involvement. [ Time Frame: Baseline and at 6 months ]

Secondary Outcome Measures:
  • Decisional quality. [ Time Frame: Baseline and at 6 months ]

Enrollment: 79
Study Start Date: May 2009
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: FRAX + Decision Aid Behavioral: FRAX + Decision Aid
Clinicians will present patient's with their individualized risk of osteoporotic fracture in 10 years, based on the FRAX risk calculator, as well as sharing a decision aid with them, which shows their risk of fracture, risk reduction on medications, as well as the downsides of the medications.
Other Name: Decision Support
No Intervention: Usual care
Experimental: FRAX estimated fracture risk Behavioral: FRAX estimated fracture risk
The clinician is provided with the patient's estimated risk of fracture as computed by the FRAX
Other Name: Risk estimate


Ages Eligible for Study:   50 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Peri and Postmenopausal Caucasian, Black, Hispanic and Asian women, aged 50-90
  • Bone mineral density (BMD) T-Score < 1.0
  • Have appointment with clinician to discuss test results and treatment options
  • Patients with FRAX <20% risk who have taken a bisphosphonate for < 5 years.

Exclusion Criteria:

  • Unable to speak or read English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00949611

United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55901
Mayo Clinic
Rochester, Minnesota, United States, 55902
Sponsors and Collaborators
Mayo Clinic
Foundation for Informed Medical Decision Making
Olmsted Medical Center
Principal Investigator: Victor M. Montori, M.D. Mayo Clinic
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Victor Montori, MD, Mayo Clinic Identifier: NCT00949611     History of Changes
Other Study ID Numbers: 08-006070
Study First Received: July 28, 2009
Last Updated: February 1, 2016

Keywords provided by Victor Montori, Mayo Clinic:
Decision Aid
Shared Decision Making
Shared Medical Decision Making

Additional relevant MeSH terms:
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases processed this record on August 18, 2017